12/20/2024
4:00 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:30 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
MITCHELL WILLIAM M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
12:38 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:41 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/16/2024
3:59 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/16/2024
3:59 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
12/13/2024
3:43 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
|
12/12/2024
3:49 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/12/2024
3:09 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
12/11/2024
7:52 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
12/10/2024
3:39 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/10/2024
8:01 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
12/10/2024
8:06 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
12/09/2024
4:25 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/06/2024
3:50 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/05/2024
3:37 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/03/2024
5:29 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
BRYAN NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:33 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
APPELROUTH STEWART (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:36 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
MITCHELL WILLIAM M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:55 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/02/2024
3:05 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
11/27/2024
4:26 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/27/2024
3:15 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
3:05 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
11/26/2024
3:05 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
11/25/2024
4:16 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/22/2024
4:26 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/21/2024
11:02 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
APPELROUTH STEWART (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
11:04 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
11:46 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
3:59 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/14/2024
3:25 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
11/14/2024
2:21 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G | |
11/06/2024
8:02 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DEFC14A | |
11/04/2024
3:59 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/04/2024
6:00 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
| Form DEFC14A | |
10/30/2024
3:50 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form PRER14A | |
10/30/2024
11:53 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form PRRN14A | |
10/18/2024
3:34 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form PREC14A | |
10/15/2024
3:33 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
| Form PREC14A | |
10/01/2024
2:55 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Why I'm telling friends to avoid gold stocks (Ad) Back in November, gold made a tiny move of 1.6%.
But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week.
It happened again in March. Gold nudged up 1.2%.
This time? A 104% overnight gain.
And in June? A 1% gold move turned into a 74% gain in two weeks.
Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now.
There's a more lucrative way to play the gold market as we enter a new breakout period.
It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. |
10/01/2024
12:12 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 424B5 | |
09/30/2024
7:22 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 424B5 | |
09/17/2024
11:05 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
2:45 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
4:15 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:45 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
4:40 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
| Form SC 13D/A | |
09/03/2024
8:43 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
| Form SC 13D/A | |
08/14/2024
6:37 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
| Form SC 13D/A | |
08/12/2024
8:39 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
8:41 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Rodino Peter W III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
5:05 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
6:14 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
| Form SC 13D/A | |
07/25/2024
11:15 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form EFFECT | |
07/25/2024
4:00 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 424B5 | |
07/15/2024
4:00 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
4:19 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
| Form SC 13D/A | |
07/11/2024
4:16 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/03/2024
9:15 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
9:05 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 424B5 | |
05/31/2024
7:14 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 424B5 | |
05/07/2024
7:30 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Rodino Peter W III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
7:30 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
11:16 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form EFFECT | |
05/01/2024
3:35 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 424B5 | |
03/29/2024
8:18 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
12:52 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
12:54 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Rodino Peter W III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
12:30 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
BRYAN NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
2:01 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
2:01 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Rodino Peter W III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
2:01 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
APPELROUTH STEWART (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
9:37 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form D/A | |
02/09/2024
2:47 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
4:00 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
12:42 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
7:45 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
7:15 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
